Phibro Animal Health (NASDAQ:PAHC) Releases FY20 Earnings Guidance

Share on StockTwits

Phibro Animal Health (NASDAQ:PAHC) issued an update on its FY20 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.08 -1.15 for the period, compared to the Thomson Reuters consensus estimate of $1.66. The company issued revenue guidance of $833 -863 million, compared to the consensus revenue estimate of $857.96 million.

Shares of Phibro Animal Health stock traded down $0.19 during trading on Tuesday, hitting $31.57. The stock had a trading volume of 169,395 shares, compared to its average volume of 161,541. The firm has a market cap of $1.25 billion, a price-to-earnings ratio of 18.14, a P/E/G ratio of 4.33 and a beta of 0.69. Phibro Animal Health has a 12 month low of $27.32 and a 12 month high of $50.40. The business’s 50-day moving average is $30.60 and its 200 day moving average is $30.99. The company has a current ratio of 3.41, a quick ratio of 1.98 and a debt-to-equity ratio of 1.48.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Wednesday, September 4th will be issued a $0.12 dividend. The ex-dividend date is Tuesday, September 3rd. This represents a $0.48 annualized dividend and a dividend yield of 1.52%. Phibro Animal Health’s payout ratio is currently 27.59%.

PAHC has been the topic of several research analyst reports. Gabelli raised shares of Phibro Animal Health from a hold rating to a buy rating and set a $42.00 price target on the stock in a report on Wednesday, May 8th. They noted that the move was a valuation call. Barclays initiated coverage on shares of Phibro Animal Health in a report on Tuesday, June 11th. They issued an underweight rating and a $25.00 price target on the stock. Zacks Investment Research raised shares of Phibro Animal Health from a sell rating to a hold rating in a report on Monday, April 29th. Guggenheim initiated coverage on shares of Phibro Animal Health in a report on Thursday, May 23rd. They issued a neutral rating on the stock. Finally, ValuEngine raised shares of Phibro Animal Health from a sell rating to a hold rating in a report on Thursday, May 23rd. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. The stock has a consensus rating of Hold and a consensus price target of $41.50.

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

See Also: Why is the conference call important?

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with's FREE daily email newsletter.